Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denecke

Showing results (941-950 of 1,080) with videos related to

Pageof 108
Sort By:
Neurogenetics|July 4, 2021
ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variantsKatja Kloth, Bernarda Lozic, Julia Tagoe, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|December 28, 2020
Bioavailability and impacts of estrogenic compounds from suspended sediment on rainbow trout (Oncorhynchus mykiss)Anne-Katrin Müller, Nele Markert, Katharina Leser, et al.
Cardiovascular and Interventional Radiology|October 30, 2021
Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancersRhea Veelken, Bettina Maiwald, Steffen Strocka, et al.
Orphanet Journal of Rare Diseases|January 31, 2026
Prevalence of avoidant/restrictive food intake disorder in children and adolescents with rare diseasesJohannes Boettcher, Thomas Lücke, Holger Zapf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 TrialUwe Pelzer, Bernhard Opitz, Gerd Deutschinoff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2012
Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profilesKaifeng Shao, Carmen Koch, Manoj K Gupta, et al.
BMC Family Practice|November 21, 2020
Evaluation of two family-based intervention programs for children affected by rare disease and their families - research network (CARE-FAM-NET): study protocol for a rater-blinded, randomized, controlled, multicenter trial in a 2x2 factorial designJohannes Boettcher, Bonnie Filter, Jonas Denecke, et al.
Cancers|October 14, 2022
Dickkopf-Related Protein 1 as Response Marker for Transarterial Chemoembolization of Hepatocellular CarcinomasAnne Olbrich, Olga Gros, Sebastian Ebel, et al.
Cancers|August 12, 2023
Evaluation of CIN2/3 Lesion Regression in GynTect<sup>®</sup> DNA Methylation-Marker-Negative Patients in a Longitudinal StudyHeike Hoyer, Claudia Stolte, Gerd Böhmer, et al.
Frontiers in Immunology|July 24, 2018
Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and SepsisKim Ohl, Athanassios Fragoulis, Patricia Klemm, et al.
Pageof 108

Showing results (941-950 of 1,080) with videos related to

Sort By:
Pageof 108
Neurogenetics|July 4, 2021
ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variantsKatja Kloth, Bernarda Lozic, Julia Tagoe, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|December 28, 2020
Bioavailability and impacts of estrogenic compounds from suspended sediment on rainbow trout (Oncorhynchus mykiss)Anne-Katrin Müller, Nele Markert, Katharina Leser, et al.
Cardiovascular and Interventional Radiology|October 30, 2021
Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancersRhea Veelken, Bettina Maiwald, Steffen Strocka, et al.
Orphanet Journal of Rare Diseases|January 31, 2026
Prevalence of avoidant/restrictive food intake disorder in children and adolescents with rare diseasesJohannes Boettcher, Thomas Lücke, Holger Zapf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 TrialUwe Pelzer, Bernhard Opitz, Gerd Deutschinoff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2012
Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profilesKaifeng Shao, Carmen Koch, Manoj K Gupta, et al.
BMC Family Practice|November 21, 2020
Evaluation of two family-based intervention programs for children affected by rare disease and their families - research network (CARE-FAM-NET): study protocol for a rater-blinded, randomized, controlled, multicenter trial in a 2x2 factorial designJohannes Boettcher, Bonnie Filter, Jonas Denecke, et al.
Cancers|October 14, 2022
Dickkopf-Related Protein 1 as Response Marker for Transarterial Chemoembolization of Hepatocellular CarcinomasAnne Olbrich, Olga Gros, Sebastian Ebel, et al.
Cancers|August 12, 2023
Evaluation of CIN2/3 Lesion Regression in GynTect<sup>®</sup> DNA Methylation-Marker-Negative Patients in a Longitudinal StudyHeike Hoyer, Claudia Stolte, Gerd Böhmer, et al.
Frontiers in Immunology|July 24, 2018
Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and SepsisKim Ohl, Athanassios Fragoulis, Patricia Klemm, et al.
Pageof 108